Edition:
United States

Vanda Pharmaceuticals Inc (VNDA.OQ)

VNDA.OQ on NASDAQ Stock Exchange Global Market

23.88USD
16 Nov 2018
Change (% chg)

$0.05 (+0.21%)
Prev Close
$23.83
Open
$23.67
Day's High
$24.06
Day's Low
$23.59
Volume
309,852
Avg. Vol
295,029
52-wk High
$25.07
52-wk Low
$12.70

Chart for

About

Vanda Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapies to address unmet medical needs. Its product portfolio includes HETLIOZ (tasimelteon), Fanapt (iloperidone), Tradipitant (VLY-686), Trichostatin A and AQW051. It offers HETLIOZ for the treatment... (more)

Overall

Beta: 0.78
Market Cap(Mil.): $1,183.79
Shares Outstanding(Mil.): 52.45
Dividend: --
Yield (%): --

Financials

  VNDA.OQ Industry Sector
P/E (TTM): 94.35 79.36 29.34
EPS (TTM): 0.24 -- --
ROI: 6.51 -0.30 13.58
ROE: 6.64 -2.98 15.11

BRIEF-Vanda Pharmaceuticals Says Hetlioz Is Effective In Treating Jet Lag During Transatlantic Travel

* HETLIOZ® (TASIMELTEON) EFFECTIVE IN TREATING JET LAG DURING TRANSATLANTIC TRAVEL

May 23 2018

Earnings vs. Estimates